IMB Dx, Inc. (KOSDAQ:461030)
2,205.00
+75.00 (3.52%)
Nov 20, 2026, 3:30 PM KST
IMB Dx Market Cap
IMB Dx has a market cap or net worth of 30.91 billion as of November 20, 2026. It is the 35,309th most valuable company in the world and the 2,081st biggest in South Korea. Its market cap has decreased by 76.69% in one year.
Market Cap
30.91B
Enterprise Value
13.26B
Revenue
5.60B
Global Rank
Country Rank
#2,081 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since April 3, 2024, IMB Dx's market cap has decreased from 503.73B to 30.91B, a decrease of -93.86%. That is a compound annual growth rate of -65.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 30.91B | -77.70% |
| Dec 30, 2025 | 138.64B | -7.14% |
| Dec 30, 2024 | 149.29B | -70.36% |
| Apr 3, 2024 | 503.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MedPacto | 125.28B |
| HLB Therapeutics | 102.77B |
| Vaxcell-Bio Therapeutics | 81.75B |
| Genexine | 80.77B |
| iNtRON Biotechnology | 76.77B |
| Amicogen | 62.42B |
| GeneOne Life Science | 48.42B |
| Prestige BioPharma | 44.35B |